ManRos Therapeutics

Start Date End Date Funded Value Relevance

CSV

25 50 100

£485,217

Mar 13 - Feb 16

MICA: Determining the therapeutic potential of targeting mTORC-1/2 in chronic lymphocytic leukaemia - a pre-clinical study

MRC award to University of Glasgow and Alison Michie

{{facetGroup.name}}

{{getFilterText(facet,showCount)}}